WuXi AppTec (OTCMKTS:WUXAY) Shares Up 7.2% – Should You Buy?

WuXi AppTec Co., Ltd. (OTCMKTS:WUXAY)’s stock price traded up 7.2% during mid-day trading on Wednesday . The stock traded as high as $17.79 and last traded at $17.79. Approximately 1,333 shares were traded during trading, a decline of 38% from the average session volume of 2,165 shares. The stock had previously closed at $16.6020.

Analysts Set New Price Targets

Separately, Zacks Research upgraded shares of WuXi AppTec to a “hold” rating in a report on Monday, April 13th. One investment analyst has rated the stock with a Buy rating and one has assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy”.

WuXi AppTec Stock Up 8.1%

The business has a 50 day moving average of $16.41 and a 200-day moving average of $15.04.

WuXi AppTec (OTCMKTS:WUXAY) last announced its earnings results on Monday, April 27th. The company reported $0.23 EPS for the quarter, beating analysts’ consensus estimates of $0.18 by $0.05. The company had revenue of $1.82 billion for the quarter, compared to analyst estimates of $1.59 billion.

About WuXi AppTec

WuXi AppTec is a global contract research, development and manufacturing organization serving the pharmaceutical, biotechnology and medical device industries. Headquartered in Shanghai and founded in 2000, the company provides end-to-end solutions that span drug discovery, development and manufacturing. Its offerings enable customers to accelerate the research and development process for small molecules, biologics, cell and gene therapies, as well as medical devices.

Key services include chemistry and biology discovery support, preclinical safety assessment, analytical and formulation development, clinical manufacturing, large-scale biomanufacturing, and quality testing.